Amgen (Brazil) Today
| AMGN34 Stock | BRL 60.18 0.78 1.28% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Amgen is trading at 60.18 as of the 3rd of December 2024, a 1.28 percent decrease since the beginning of the trading day. The stock's open price was 60.96. Amgen has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Amgen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. AMGEN DRN operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 14.95 B outstanding shares. More on Amgen Inc
Moving together with Amgen Stock
Moving against Amgen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Amgen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amgen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Robert Bradway |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Amgen Inc (AMGN34) is traded on Sao Paulo Exchange in Brazil and employs 25,200 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 685.32 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amgen Inc operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 14.95 B outstanding shares.
Amgen Inc has accumulated about 7.18 B in cash with 9.72 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Check Amgen Probability Of Bankruptcy
Amgen Inc Risk Profiles
Although Amgen's alpha and beta are two of the key measurements used to evaluate Amgen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.49 | |||
| Standard Deviation | 2.26 | |||
| Variance | 5.09 | |||
| Risk Adjusted Performance | (0.02) |
Amgen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Amgen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Amgen Corporate Directors
| Tyler Jacks | Independent Director | Profile | |
| Gregory Garland | Independent Director | Profile | |
| Charles Holley | Independent Director | Profile | |
| Ellen Kullman | Independent Director | Profile |
Additional Information and Resources on Investing in Amgen Stock
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.